Replies to post #24772 on Delcath Systems Inc (DCTH)

[Rapture2020]

Nonsense. This is all that you need to know until next quarter, IMO:

Increasing revenues and a liver cancer treatment in Phase III trials are two key factors in what continues to make us interested in the DCTH story.

[Maple tree]

Total share right now is under 1.7 millions and I am sure that share number will be increased at some point. Company could try to go back to NASDAQ before raising additional fund. It is absolutely undervalued now and market cap is worth at least 50 millions. Stock price has more room to run